The overarching aim of the Northern New England Clinical and Translational Research Network (NNE-CTR) is to establish the necessary infrastructure to conduct high-quality clinical and translational research that will ultimately improve health outcomes for residents in this largely rural region. To achieve this ambitious aim, NNE-CTR leadership and staff will need to develop systems to continuously assess progress and identify opportunities for mid-course corrections. The Tracking and Evaluation Core (TEC) will provide the requisite infrastructure to ensure that the NNE-CTR can establish its own value and efficiency, and enact needed program improvements in a timely and effective manner. Led by a multidisciplinary team of evaluation, outcomes research and quality improvement experts, the functions of the TEC will be to: 1) identify meaningful and reliable performance metrics for the overall program, and the individual Key Component Activities; 2) continually track and monitor these metrics; and 3) rigorously analyze, synthesize, and disseminate performance information to NNE-CTR leadership and key stakeholders throughout the implementation process. Working collaboratively with Maine Medical Center and the University of Vermont, TEC staff will use a flexible, stakeholder-centered approach to facilitate the selection of performance metrics for each Core and the broader NNE-CTR initiative; implement and customize the REDCap data portal to support tracking and data collection; collect primary qualitative and quantitative data relevant to the conduct of clinical and translational research; routinely analyze and report performance data to the NNE-CTR leadership and key stakeholders; respond to evaluation consultation requests from other Cores; and produce summative reports of activities and outcomes of the IDeA-CTR award. The TEC activities will be grounded in the Center for Disease Control and Preventions' evaluation framework, which applies a population health model ideal for evaluating the health and systems-level outcomes of clinical and translational research. To complement the CDC model, the TEC Core will also adopt the ?systems evaluation partnership? model to assess a broad range of process and short- and long-term outcome measures. In addition, the TEC will apply quality improvement tools and techniques in tandem with more traditional evaluation methods to provide the NNE-CTR leadership and stakeholders with actionable rapid cycle feedback to help inform implementation efforts and identify opportunities for improvement. Through these activities, the TEC will facilitate transparency, promote data-informed decisions regarding the management of the initiative's many components, and thereby ensure the ultimate success of the overall program.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54GM115516-01A1
Application #
9361853
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Maine Medical Center
Department
Type
DUNS #
071732663
City
Portland
State
ME
Country
United States
Zip Code
04102
Mistry, Swaroop D; Woods, Gina N; Sigurdsson, Sigurdur et al. (2018) Sex hormones are negatively associated with vertebral bone marrow fat. Bone 108:20-24
Stohn, J P; Martinez, M E; Zafer, M et al. (2018) Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems. Genes Brain Behav 17:23-35
Guntur, Anyonya R; Gerencser, Akos A; Le, Phuong T et al. (2018) Osteoblast-like MC3T3-E1 Cells Prefer Glycolysis for ATP Production but Adipocyte-like 3T3-L1 Cells Prefer Oxidative Phosphorylation. J Bone Miner Res 33:1052-1065
van der Spek, Anne H; Jim, Kin Ki; Karaczyn, Aldona et al. (2018) The Thyroid Hormone Inactivating Type 3 Deiodinase Is Essential for Optimal Neutrophil Function: Observations From Three Species. Endocrinology 159:826-835
Ji, Yaoting; Liu, Peng; Yuen, Tony et al. (2018) Epitope-specific monoclonal antibodies to FSH? increase bone mass. Proc Natl Acad Sci U S A 115:2192-2197
Craig, Alexa K; Gerwin, Roslyn; Bainter, Janelle et al. (2018) Exploring Parent Experience of Communication About Therapeutic Hypothermia in the Neonatal Intensive Care Unit. Adv Neonatal Care 18:136-143
Davis-Knowlton, Jessica; Turner, Jacqueline E; Turner, Anna et al. (2018) Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling. Lab Invest :
Juraschek, Stephen P; Plante, Timothy B; Charleston, Jeanne et al. (2018) Use of online recruitment strategies in a randomized trial of cancer survivors. Clin Trials 15:130-138
Tracy, Kirsten M; Tye, Coralee E; Ghule, Prachi N et al. (2018) Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer. Mol Cancer Res 16:587-598
Gilsanz, Vicente; Wren, Tishya A L; Ponrartana, Skorn et al. (2018) Sexual Dimorphism and the Origins of Human Spinal Health. Endocr Rev 39:221-239

Showing the most recent 10 out of 21 publications